Target Name: MTMR11
NCBI ID: G10903
Review Report on MTMR11 Target / Biomarker Content of Review Report on MTMR11 Target / Biomarker
MTMR11
Other Name(s): Myotubularin-related protein 11 | MTMRB_HUMAN | Cisplatin resistance-associated protein | inactive phosphatidylinositol 3-phosphatase 11 | CRA | Cisplatin resistance associated | myotubularin related protein 11 | Myotubularin-related protein 11 (isoform b) | cisplatin resistance-associated protein | OTTHUMP00000014063 | hCRA | MTMR11 variant 2 | RP11-212K13.1 | cisplatin resistance associated | Inactive phosphatidylinositol 3-phosphatase 11 | Myotubularin related protein 11, transcript variant 2

MTMR11: A Protein Involved in Muscle Development, Maintenance and Injury Repair

MTMR11, also known as Myotubularin-related protein 11, is a protein that is expressed in human muscle tissue and is known for its role in muscle development and maintenance. The protein is composed of 156 amino acids and has a calculated molecular weight of 19.9 kDa. It is localized to the sarcolemma of muscle cells and is involved in several processes that are essential for muscle function, including muscle growth, repair, and maintenance.

One of the key functions of MTMR11 is its role in muscle cell signaling. The protein is involved in the regulation of several signaling pathways that are critical for muscle development and function, including the TGF-β pathway and the Wnt pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and repair, and is a key factor in muscle development and maintenance. The Wnt pathway is a signaling pathway that is involved in the regulation of cell growth and differentiation, and is also important for muscle development and maintenance.

Another function of MTMR11 is its role in muscle injury and repair. MTMR11 has been shown to play a key role in the regulation of muscle injury and repair, including the process of muscle contusion. Muscle contusion is a common injury that occurs as a result of trauma or exercise, and is characterized by the damage of muscle tissue. MTMR11 has been shown to be involved in the regulation of the inflammatory response and the repair process following muscle contusion, by promoting the production of pro-inflammatory cytokines and inhibiting the production of anti-inflammatory cytokines.

In addition to its role in muscle signaling and injury repair, MTMR11 is also thought to be involved in the regulation of cell survival. The protein has been shown to be involved in the regulation of cell survival and proliferation, by promoting the production of pro-inflammatory cytokines and inhibiting the production of anti-inflammatory cytokines. This suggests that MTMR11 may play a key role in the regulation of cell survival and may be a potential drug target.

MTMR11 is also a potential biomarker for muscle disease, as its levels have been shown to be altered in several muscle diseases, including muscle protein synthesis disorders, myopathies, and neurodegenerative diseases. This suggests that MTMR11 may be a useful biomarker for the diagnosis and treatment of these diseases.

In conclusion, MTMR11 is a protein that is involved in several processes that are essential for muscle development, maintenance, and injury repair. Its role in these processes makes it a potential drug target and a useful biomarker for the diagnosis and treatment of muscle diseases. Further research is needed to fully understand the functions of MTMR11 and to develop effective treatments for muscle-related diseases.

Protein Name: Myotubularin Related Protein 11

The "MTMR11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTMR11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MTMR12 | MTMR14 | MTMR2 | MTMR3 | MTMR4 | MTMR6 | MTMR7 | MTMR8 | MTMR9 | MTMR9LP | MTND1P11 | MTND1P23 | MTND1P3 | MTND1P33 | MTND2P21 | MTND2P28 | MTND4P10 | MTND4P12 | MTND4P17 | MTND4P22 | MTND4P24 | MTND4P28 | MTND4P29 | MTND5P10 | MTND5P16 | MTND5P19 | MTND5P20 | MTND5P31 | MTND5P8 | MTND6P14 | MTND6P4 | MTNR1A | MTNR1B | MTO1 | MTOR | mTOR complex 1 | mTOR complex 2 | MTPAP | MTPN | MTR | MTRES1 | MTREX | MTRF1 | MTRF1L | MTRF1LP2 | MTRFR | MTRNR2L1 | MTRNR2L10 | MTRNR2L11 | MTRNR2L12 | MTRNR2L13 | MTRNR2L2 | MTRNR2L3 | MTRNR2L4 | MTRNR2L5 | MTRNR2L6 | MTRNR2L7 | MTRNR2L8 | MTRNR2L9 | MTRR | MTSS1 | MTSS2 | MTTP | MTURN | MTUS1 | MTUS1-DT | MTUS2 | MTUS2-AS1 | MTVR2 | MTX1 | MTX2 | MTX3 | mu-Calpain (calpain 1) | MUC1 | MUC12 | MUC13 | MUC15 | MUC16 | MUC17 | MUC19 | MUC2 | MUC20 | MUC20P1 | MUC21 | MUC22 | MUC3A | MUC3B | MUC4 | MUC5AC | MUC5B | MUC6 | MUC7 | MUC8 | Mucin | MUCL1 | MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex | MUPP | MUS81